-
Molecular processes underlying neuromuscular junction denervation in humans with ALS
https://braincanada.ca/fr/subventions-financées/molecular-processes-underlying-neuromuscular-junction-denervation-in-humans-with-alsAmyotrophic lateral sclerosis (ALS) is marked by dysfunction and degeneration of neuromuscular junctions (NMJ). Project Overview Amyotrophic lateral sclerosis (ALS) is marked by dysfunction and degeneration of neuromuscular junctions (NMJ). This can be one of the earliest pathological processes...
-
Molecular regulators of extracellular matrix remodeling during Amyotrophic Lateral Sclerosis
https://braincanada.ca/fr/subventions-financées/molecular-regulators-of-extracellular-matrix-remodeling-during-amyotrophic-lateral-sclerosisAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by the loss of motor neurons and the atrophy of muscles. Project Overview Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by the loss of motor neurons and the atrophy of...
-
Monitoring and Modulation of Alpha Synuclein in Microglia: Implications for Parkinson’s Disease
https://braincanada.ca/fr/subventions-financées/monitoring-and-modulation-of-alpha-synuclein-in-microglia-implications-for-parkinson-s-diseaseIn this study, we. aim to do two things: 1) monitor the distribution of a-Syn in Parkinson’s disease (PD) context to understand the factors that can cause a-Syn to build-up in certain cells of the brain, called microglia. Project Overview In this study, we. aim to do two things: 1) monitor the...
-
Montreal functional brain imaging platform
https://braincanada.ca/fr/subventions-financées/montreal-functional-brain-imaging-platformDr. Shmuel and his team are establishing a local platform which will support functional MRI (fMRI) in the alert non-human primate brain. Project Overview Dr. Shmuel and his team are establishing a local platform which will support functional MRI (fMRI) in the alert non-human primate brain. The...
-
Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants
https://braincanada.ca/fr/subventions-financées/montreal-integrated-neuropsychiatric-cohort-identifying-subtypes-of-autism-and-schizophrenia-integrating-genomics-endophenotypes-and-cohorts-of-high-risk-genetic-variantsAutism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ. Project Overview Autism spectrum disorders (ASD) and schizophrenia...
-
Mouse brain imaging for neurodevelopmental disorders
https://braincanada.ca/fr/subventions-financées/mouse-brain-imaging-for-neurodevelopmental-disordersThe project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders. Project Overview The project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders. The use of...
-
MouseTRAP: The Mouse Translational Research Accelerator Platform
https://braincanada.ca/fr/subventions-financées/mousetrap-the-mouse-translational-research-accelerator-platformNeurodegenerative conditions such as Alzheimer’s and Parkinson’s disease profoundly affect aspects of cognition including memory Project Overview Neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease profoundly affect aspects of cognition including memory, attention, decision...
-
MRI Biomarkers of Cerebral Degeneration in ALS and their Pathological Validation
https://braincanada.ca/fr/subventions-financées/mri-biomarkers-of-cerebral-degeneration-in-als-and-their-pathological-validationA biological marker, or “biomarker” for short, is a measurable indicator associated with a disease state that helps determine risk, severity and response to therapy. Project Overview A biological marker, or “biomarker” for short, is a measurable indicator associated with a disease state that helps...
-
Multi-modal neuroimaging biomarkers of Parkinson’s disease progression
https://braincanada.ca/fr/subventions-financées/multi-modal-neuroimaging-biomarkers-of-parkinson-s-disease-progressionParkinson’s disease (PD) is one of the most common neurodegenerative disorders in the world. Project Overview Parkinson’s disease (PD) is one of the most common neurodegenerative disorders in the world. PD can manifest and develop in a variety of ways for different patients, and it is currently not...
-
Multi-scale analyses of brain connectivity and dynamics in autism spectrum conditions
https://braincanada.ca/fr/subventions-financées/multi-scale-analyses-of-brain-connectivity-and-dynamics-in-autism-spectrum-conditionsAutism spectrum disorder (ASD) affects approximately 1 in 70 children and is associated to a considerable burden for affected individuals, their families, and health care at large. Project Overview Autism spectrum disorder (ASD) affects approximately 1 in 70 children and is associated to a...